SNWV Stock Forecast: SANUWAVE Health, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 53 of 100 as at 21 Nov 2026 — in the upper half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores SANUWAVE Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (99): The business earns solid, repeatable profits on what it owns.
Momentum (2): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
SNWV stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on SNWV, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 30 Mar 2026 | Roth Capital | Reiterates | Buy | $53 → $47 |
| 3 Sept 2025 | Northland Capital Markets | Initiates | Outperform | — |
| 22 Aug 2025 | Roth Capital | Maintains | Buy | — |
| 29 July 2025 | Roth Capital | Initiates | Buy | — |
| 15 Sept 2020 | Lake Street | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for SNWV.
This page is one stock. Monday covers all of them.
SNWV appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
SNWV vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, SANUWAVE Health, Inc. returned −95.3% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
SNWV analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 0.3×
- Price / book
- 4.5×
- EV / EBITDA
- 11.0×
Cheaper than 86% of US stocks
Cheaper than 20% of US stocks
Cheaper than 51% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 76.2%
- Operating margin
- 2.6%
- Net margin
- —
Higher than 88% of US stocks
Higher than 47% of US stocks
- Return on equity
- 729.6%
- Return on assets
- 2.0%
- Dividend yield
- —
Higher than 99% of US stocks
Higher than 58% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
SANUWAVE Health, Inc. has a market value of $12.9M and an enterprise value of $25.9M.
Revenue in the twelve months to 30 June 2026: $43.9M. The latest quarter shrank 4.2% year on year.
Net income over the same four quarters: $14.3M, a 32.6% net margin.
Free cash flow in the twelve months to 30 June 2026: $4.0M.
SANUWAVE Health, Inc. employs 55 people — $798K of revenue per employee.
Data provided by Twelve Data
SNWV and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at SNWV’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own SANUWAVE Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about SNWV
Is SNWV stock a buy right now?
Of the 1 analyst covering SANUWAVE Health, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SANUWAVE Health, Inc. 53 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank SNWV?
As at 21 Nov 2026, SANUWAVE Health, Inc. ranks 53 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Quality (99 of 100).
What is the SNWV stock forecast for 2030?
No analyst covering SANUWAVE Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SNWV are extrapolating price history, which says nothing about the business.
How has SNWV stock performed over the past year?
SANUWAVE Health, Inc. returned -95.3% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does SANUWAVE Health, Inc. do?
SANUWAVE Health, Inc. Common Stock represents a medical device company focused on noninvasive energy-based therapies for wound care and regenerative healing. SANUWAVE develops and markets ultrasound and shockwave systems designed to support the treatment of acute and chronic wounds, with its UltraMIST platform serving as a key commercial product.
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. Common Stock represents a medical device company focused on noninvasive energy-based therapies for wound care and regenerative healing. SANUWAVE develops and markets ultrasound and shockwave systems designed to support the treatment of acute and chronic wounds, with its UltraMIST platform serving as a key commercial product. The company also works in related areas such as tissue, musculoskeletal, and vascular repair, positioning its technologies within advanced wound management and regenerative medicine. Its business is centered on designing and selling medical devices to healthcare providers, with products used in clinical settings that require targeted, non-contact therapeutic solutions. SANUWAVE Health, Inc. Common Stock is associated with a healthcare technology business that addresses specialized treatment needs across wound care and tissue recovery markets.
CEO Mr. Morgan C. Frank · 55 employees · United States · https://sanuwave.com